Live search
TopFind is fetching the latest matches for your search.
We reviewed 15 live results for trazimera trastuzumab and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Oncology and Monoclonal Antibodies.
Source: Pfizer Philippines Inc.
Description
Trazimera is a monoclonal antibody biosimilar for the treatment of HER2-positive breast and stomach cancers, receiving PH FDA approval in 2022.
Best for
HER2 Positive breast cancer, Stomach cancer and Targeted oncology therapy
Rating
Source: Celltrion Healthcare
Description
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Best for
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy and Oncology infusion treatment
Rating
Source: Biocon Biologics Philippines Inc.
Description
A biosimilar monoclonal antibody for the treatment of HER2-positive breast and gastric cancers, available in the Philippines since 2018.
Best for
HER2 Positive breast cancer, Gastric cancer treatment and Oncology therapy
Rating
| Compare | Trazimera (Trastuzumab) | Herzuma (Trastuzumab) | Trastuzumab Biosimilar |
|---|---|---|---|
| Source | Pfizer Philippines Inc. | Celltrion Healthcare | Biocon Biologics Philippines Inc. |
| Description | Trazimera is a monoclonal antibody biosimilar for the treatment of HER2-positive breast and stomach cancers, receiving PH FDA approval in 2022. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. | A biosimilar monoclonal antibody for the treatment of HER2-positive breast and gastric cancers, available in the Philippines since 2018. |
| Best for | HER2 Positive breast cancer, Stomach cancer and Targeted oncology therapy | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy and Oncology infusion treatment | HER2 Positive breast cancer, Gastric cancer treatment and Oncology therapy |
| Action | |||
| Rating |
If you want the most balanced option to start with, I recommend:
"Trazimera (Trastuzumab) from Pfizer Philippines Inc.."
I picked this because Trazimera is a recently approved, high-standard biosimilar for targeted HER2-positive cancer therapy.